Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer

The prognostic value of long noncoding RNA MEG3 expression in the survival of patients with cancer: A meta-analysis

(2018) Maryam Moradi Binabaj et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway

(2017) Ling Zhang et al.   ONCOLOGY REPORTS

LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis

(2017) Pei Wang et al.   OncoTargets and Therapy

Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics

(2017) Jing Peng et al.   Cancer Management and Research

Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients

(2017) Youhong Wang et al.   Scientific Reports

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

(2015) A. S. Coates et al.   ANNALS OF ONCOLOGY

Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates

(2015) Mehra Golshan et al.   ANNALS OF SURGERY

Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients

(2015) Aysha Karim Kiani et al.   IMMUNOGENETICS

Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway

(2015) YANG XIA et al.   Molecular Medicine Reports

The emerging role of lncRNAs in cancer

(2015) Maite Huarte   NATURE MEDICINE

The role and interaction of imprinted genes in human fetal growth

(2015) G. E. Moore et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA–DNA triplex structures

(2015) Tanmoy Mondal et al.   Nature Communications

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

(2014) Gunter von Minckwitz et al.   LANCET ONCOLOGY

MEG3 noncoding RNA: a tumor suppressor

(2012) Yunli Zhou et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

A simple system for grading the response of breast cancer to neoadjuvant chemotherapy

(2009) S. Rodenhuis et al.   ANNALS OF ONCOLOGY

The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes

(2009) Chris Wallace et al.   NATURE GENETICS